Lightnews — Scholar-powered news

Reposted by Thermal

Innovative Genomics Institute @innovativegenomics.bsky.social · 6d

From IGI Founder Jennifer Doudna: "Jane Goodall showed us what a life in science could look like: rigorous discovery paired with fierce advocacy for what you study. She gave the world six decades of groundbreaking research on chimpanzees and their habitats... 1/2

1 10 33

Reposted by Thermal

Scribe Therapeutics @scribetx.bsky.social · 8d

Ahead of #WorldHeartDay, Taylor Swift recently raised an important reminder: heart disease is the leading cause of death, and one person dies from it every 34 seconds.

For some, including her father, a routine stress test revealed severe disease early enough to undergo surgery.

1 1 3

Reposted by Thermal

Scribe Therapeutics @scribetx.bsky.social · 13d

An important piece in @forbes.com by Leaps By Bayer highlighting the dangers of high cholesterol, the urgent need for solutions beyond statins, and Scribe’s advances developing #CRISPR gene editing and epigenetic silencing therapies for cardiometabolic disease.

www.forbes.com/sites/juerge...

Treating High Cholesterol Could Become A One-And-Done Treatment

Gene editing and epigenetic silencing offer two ways of changing the basic biology of cholesterol for future treatments beyond statins.

www.forbes.com

1 1

Thermal @thermalpr.com · 26d

Check out ON CRISPR: The Story of Jennifer Doudna - a new podcast from Walter Isaacson about the story of @jenniferdoudna.bsky.social - CRISPR co-inventor, Nobel laureate, @innovativegenomics.bsky.social founder - and key updates, including the case of Baby KJ. podcasts.apple.com/us/podcast/o...

ON CRISPR Episode 1: Beginnings

Podcast Episode · ON CRISPR: The Story of Jennifer Doudna with Walter Isaacson · S3 E1 · 26m

podcasts.apple.com

Reposted by Thermal

Scribe Therapeutics @scribetx.bsky.social · 29d

📣 Presenting new breakthrough data from two of our core platforms 📣

We're proud to showcase the success of our Lp(a)-lowering therapy STX-1200 and novel #AI platform, DeepXE, for next-generation #CRISPR-based therapeutics.

More details in our link below 👇

1 1 1

Thermal @thermalpr.com · Sep 8

Thanks to Amy Marcus, Alex Janin, and Shane Shifflett @wsj.com for covering the $5B longevity investment landscape, including our clients BioAge and Retro, and the ecosystem of companies working to translate aging research into therapies for longer, healthier lives.
www.wsj.com/health/welln...

The Billionaires Fueling the Quest for Longer Life

A network of ultrawealthy investors including Peter Thiel and Sam Altman are infusing the longevity industry with cash and making big bets on where the science is headed.

www.wsj.com

Reposted by Thermal

Scribe Therapeutics @scribetx.bsky.social · Aug 25

This fall, we are thrilled to present our latest updates on our #CRISPR genetic and epigenetic editing therapies, new machine learning approach, and corporate strategy at several premier conferences.

If you’ll be at #ECCongress, #CGMesa25, and others, read on for more details 👇

1 1 1

Reposted by Thermal

Andrew Dunn @andrewedunn.bsky.social · Aug 22

Exclusive: I talked with leaders of OpenAI and Retro Bio about new lab results from an AI protein model called GPT-4b micro.

While the model won't be released publicly, the research shows how LLMs could be applied to life sciences research:
endpoints.news/openai-retro...

Exclusive: OpenAI, Retro Bio detail lab results with AI protein model, plan use in drug program

OpenAI and Retro Biosciences report AI-made proteins showed 50x better cell reprogramming using modified Yamanaka factors, with potential therapeutic applications

endpoints.news

1 2

Reposted by Thermal

Andrew Dunn @andrewedunn.bsky.social · Jul 29

Exclusive: Formation Bio raised a $372M Series D last year.

Later today, the New York biopharma will announce its first licensing deal since raising that money — bringing in a CD226 antibody from the Spanish biotech IMIDomics.

My latest for @endpts.com: endpoints.news/exclusive-fo...

Exclusive: Formation licenses first drug since $372M raise, eyes more deals in 2025

Formation Bio licenses first-in-class anti-CD226 antibody from IMIDomics for IBD treatment, marking first drug acquisition since $372M Series D raise in 2023.

endpoints.news

1 2

Thermal @thermalpr.com · Jul 29

CRISPR pioneer and Nobel laureate @jenniferdoudna.bsky.social is featured in the inaugural issue of The Shift. This first issue honors Gloria Steinem's legacy and brings together 90 extraordinary women whose work is opening doors for future generations. theshiftison.com/jennifer-dou...

Reposted by Thermal

Innovative Genomics Institute @innovativegenomics.bsky.social · Jul 17

We’re thrilled to announce IGI–Bakar Labs. This new building will allow the IGI to continue expanding our impact in health and agricultural applications of #CRISPR, and will be shared with the Bakar Labs incubator for growing biotech companies. Learn more: news.berkeley.edu/2025/07/17/c...

CRISPR researchers and startup entrepreneurs will share new building in UC Berkeley's Innovation Zone - Berkeley News

A planned addition to the campus's Innovation Zone will expand lab space for the Innovative Genomics Institute and build out the largest innovation hub — Bakar Labs — at any U.S. university.

news.berkeley.edu

1 18 33

Reposted by Thermal

Eric Topol @erictopol.bsky.social · Jul 8

A new Pediatric Center for CRISPR Cures builds on the recent saved life of Baby KJ, who expeditiously had bespoke in vivo base genome editing
@jenniferdoudna.bsky.social @doudna-lab.bsky.social
@innovativegenomics.bsky.social
@chanzuckerberg.bsky.social
erictopol.substack.com/p/new-center...

Our conversation photo and photo of Baby KKJ

3 28 150

Reposted by Thermal

Innovative Genomics Institute @innovativegenomics.bsky.social · Jul 8

We're excited to announce that the IGI is teaming up with @chanzuckerberg.bsky.social to create a new center for pediatric #CRISPR cures @UCSF + @ucberkeleyofficial.bsky.social building on the recent success of an on-demand CRISPR therapy for Baby KJ. Read more: ow.ly/XUQH50Wmt7U

Aysel Ogul, an undergraduate research assistant at the IGI, pipetting in the lab with her mentor Kevin Briseno

2 8

Reposted by Thermal

Nautilus Biotechnology @nautilus.bio · Jul 1

On the blog, we’re diving into data from our new preprint covering Iterative Mapping of proteoforms. Today we focus on the method, its benefits, and why the analysis of tau proteoforms is a great exemplar for the power of this work:

www.nautilus.bio/blog/iterati...

#Proteomics #Proteoforms

Iterative Mapping of proteoforms may reveal novel biology and new drug targets

Learn how Iterative Mapping of proteoforms can provide novel insights into biology with tau proteoforms as exemplars.

www.nautilus.bio

1 5

Thermal @thermalpr.com · Jun 19

Read @faylinphd.bsky.social’s article for more context. www.genengnews.com/topics/artif...

Agenus and Noetik Collaboration Will Predict Cancer Biomarkers Using the Virtual Cell

Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead immuno-oncology combination, BOT/BAL.

www.genengnews.com

Thermal @thermalpr.com · Jun 19

Agenus and Noetik announced a collaboration to develop AI-enabled predictive biomarkers for BOT/BAL using foundation models of “virtual cell” biology. www.businesswire.com/news/home/20...

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology

www.businesswire.com

1

Thermal @thermalpr.com · Jun 16

Joe Betts-LaCroix (CEO of Retro Bio) has bigger concerns - he wants to add another ten years to the lifespan of half the world’s population.

“I’d like to know how my body works and, if it’s going to break, I’d like to know how to prevent that.”
www.thetimes.com/world/europe...

I witnessed the birth of an immortality cult — surely it can’t last?

The tech bros believe we are close to conquering death. Matt Rudd travels to the ‘superhuman summit’ in Stockholm to sample body scanners and bone broth

www.thetimes.com

Thermal @thermalpr.com · Jun 13

“The Hidden Barriers Holding Back Cancer’s Most Promising Treatments” by Georgiamune CEO Samir N. Khleif for TIME.
time.com/7292783/canc...

The Hidden Barriers Holding Back Promising Cancer Treatments

A perfect storm of scientific, economic, and cultural barriers are holding back immunotherapy's true potential, writes Samir Khleif.

time.com

Thermal @thermalpr.com · Jun 13

Genesis Therapeutics Appoints Aleksandra Faust
as Chief Artificial Intelligence Officer.

Former Google DeepMind Director brings over two decades of AI research expertise and industrial leadership to Genesis’ AI platform and high-performing research teams.
www.businesswire.com/news/home/20...

Genesis Therapeutics Appoints Aleksandra Faust as Chief Artificial Intelligence Officer

Genesis Therapeutics appoints Aleksandra Faust as Chief Artificial Intelligence Officer

www.businesswire.com

Reposted by Thermal

Innovative Genomics Institute @innovativegenomics.bsky.social · Jun 12

Thanks to the BBC's The Inquiry program for great conversations with IGI's @jenniferdoudna.bsky.social @doudna-lab.bsky.social and @urnov.bsky.social about Baby KJ, #CRISPR on-demand, and the future of personalized medicine!

Listen here: www.bbc.com/audio/play/w...

Photo credit: TODAY

3 8

Thermal @thermalpr.com · Jun 5

🧬CRISPR is moving at breakneck speed! Join @jenniferdoudna.bsky.social and @emilychang.bsky.social on 6/5 for a live episode of #TheCircuit at #BloombergTech. From curing baby KJ to AIxCRISPR, this will be a candid conversation on gene editing's impact and future.
Livestream: www.bloomberg.com/live

1

Reposted by Thermal

Carolyn Johnson @carolynyjohnson.bsky.social · Jun 3

In case you needed a smile this Tuesday: 10-month-old baby KJ, who received a bespoke gene-editing therapy after a six month scientific sprint - "graduated" from the hospital @childrensphila.bsky.social today and went HOME!

YAY SCIENCE!

Here's his story: wapo.st/451ZQjT

6 63 360

Thermal @thermalpr.com · Jun 4

BioAge Labs announced today a breakthrough dual-track approach to exercise mimetic obesity treatment that could solve major limitations of current GLP-1 therapies by targeting energy expenditure rather than just appetite suppression.
www.globenewswire.com/news-release...

BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates

Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically...

www.globenewswire.com

Thermal @thermalpr.com · May 29

US supercomputer named after Nobel laureate Jennifer Doudna to power AI and scientific research
apnews.com/article/nvid...

US supercomputer named after Nobel laureate Jennifer Doudna to power AI and scientific research

A new supercomputer named after a winner of the Nobel Prize in chemistry will help power artificial intelligence technology and scientific discoveries from a perch in the hills above the University of...

apnews.com

Thermal @thermalpr.com · May 29

BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic.
www.globenewswire.com/news-release...

BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic

IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102 induced weight loss in preclinical obesity models, both as...

www.globenewswire.com